CCL18 and gastric cancer: Additionally, miR-484 has been observed to target CC chemokine ligand 18 (CCL-18) through the PI3K/AKT signaling pathway, thereby inducing G1 phase cell cycle arrest, inhibiting cell proliferation, and promoting apoptosis of gastric cancer cells [33].